Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PRLD compared with EWTX: revenue, margins and what each company keeps, and the suppliers and customers both name
PRLD
Prelude Therapeutics Inc
Change
Mkt cap
Revenue
Revenue
EWTX
Edgewise Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PRLD
Prelude Therapeutics Inc
vs
EWTX
Edgewise Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
PRLD
Prelude Therapeutics Inc
Change
3.89
· pre 3.89
· delayed
Mkt cap
$309.6M
Revenue
$6M
Q2 FY26
EWTX
Edgewise Therapeutics, Inc.
Change
38.93
· pre 39.06
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$4.2B
Revenue
—
vs
Compare
Pre-market
Oct 30 '26
delayed
PRLD
Prelude Therapeutics Inc
vs
EWTX
Edgewise Therapeutics, Inc.
3.89
pre 3.89
delayed
Price
38.93
pre 39.06
delayed
$309.6M
Mkt cap
$4.2B
Q2 FY26
$6M
Revenue
—
Change
Change
PRLD
3.89
vs
EWTX
38.93
Pre-market
Oct 30 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PRLD, solid
EWTX, dashed
Supply-chain overlap
Revenue flow
PRLD: latest quarter is a loss; flow not drawable. EWTX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only PRLD
3
INCY
Incyte
customer
ABCL
AbCellera Biologics
customer
—
Pathos AI
unlisted
customer
Shared
0
No shared counterparties.
Only EWTX
2
—
Leerink
unlisted
supplier
—
Silicon Valley Bank (SVB)
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR